John Aballi Insider Trades & Stock Holdings

President and CEO · Exagen Inc. · Latest filing Oct 16, 2026

John Aballi, President and CEO at Exagen Inc. has 1 Form 4 trade on file since Oct 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($269.79K), net -$269.79K. Latest filing: disposed of 34.29K shares of $XGN on Oct 16, 2026 at $7.87.

Trades on file

1

Open-market bought

$0

Open-market sold

$269.79K

Net open-market

-$269.79K

Shares held ($XGN)

805.54K

Latest filing

Oct 16, 2026

Shares held by John Aballi

• $XGN805.54K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by John Aballi

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 16, 2026	$XGN	Sell (Open-market sale)	34.29K	$7.87	$269.79K	805.54K	-4.08%				President and CEO	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks John Aballi traded

• $XGN

Frequently asked questions

Has John Aballi been buying or selling stock?

John Aballi has 0 open-market purchases and 1 open-market sale on file, net -$269.79K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was John Aballi's latest insider trade?

disposed of 34.29K shares of $XGN on Oct 16, 2026 at $7.87.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.